Wencui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Wencui Li has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Xiaoqiang Chen
Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
9 shared publicationsJianquan Liu
Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
8 shared publicationsZhe Zhao
Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
7 shared publicationsZhiqin Deng
Hand and Foot Surgery Department Shenzhen Second People's Hospital/The First Hospital Affiliated to Shenzhen University, Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital Shenzhen China
5 shared publications- Zhiqin Deng
Hand and Foot Surgery Department, Shenzhen Second People’s Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, China
5 shared publications Daping Wang
Hand and Foot Surgery Department, Shenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University), Shenzhen, Guangdong 518000, P.R. China
4 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Comparative repair efficacy of three mesenchymal stem cell sources in rat full-thickness talar cartilage defects
Ankle cartilage damage frequently progresses to osteoarthritis (OA), which impairs patient quality of life and creates substantial socioeconomic burdens worldwide. Mesenchymal stem cells (MSCs) offer a promising approach for cartilage regeneration; however, comparative data on the efficacy of MSCs from different tissue sources for ankle cartilage repair remains limited. As an exploratory preclinical study, this investigation aimed to evaluate and compare the effects of bone marrow-derived MSCs (BMMSCs), adipose-derived MSCs (ADMSCs), and synovial fluid-derived MSCs (SFMSCs) in a rat model of full-thickness talar cartilage defects. Full-thickness talar cartilage defects were created by limited-depth drilling in 8-week-old male Sprague-Dawley rats (200–300 g). Animals were randomly assigned to a control group or three treatment groups receiving intra-articular injection of BMMSCs, ADMSCs, or SFMSCs. Outcomes were assessed using behavioral and gait tests, footprint analysis, Micro-CT imaging for subchondral bone parameters (BS/TV, Tb.N, Tb.Sp), ICRS macroscopic scoring, histopathological evaluation, and immunohistochemical staining for chondrogenic markers (Col II, FSTL1, SOX9, Smad3). In this exploratory analysis, the SFMSC group displayed comparatively better functional recovery in behavioral and gait measurements relative to other groups. The footprint length factor was significantly higher in the SFMSC group (6.76 ± 1.15) than in the control group (5.52 ± 1.68, P < 0.05), and the ICRS score was also elevated in the SFMSC group (11.00 ± 1.26 vs. 8.80 ± 1.32 in controls, P < 0.01). No significant differences in subchondral bone Micro-CT parameters were detected among groups (P > 0.05). Histological and immunohistochemical findings suggested that SFMSCs were associated with enhanced hyaline cartilage formation and relatively higher expression of chondrogenic markers at the defect site. Within the constraints of this exploratory preclinical study, SFMSCs showed comparatively favorable effects on talar cartilage repair in rats relative to BMMSCs and ADMSCs. These preliminary findings support SFMSCs as a promising candidate source for stem cell-based ankle cartilage regeneration, providing exploratory evidence that may inform future investigations toward clinical translation.
- 8 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessComparative repair efficacy of three mesenchymal stem cell sources in rat full-thickness talar cartilage defects
Ankle cartilage damage frequently progresses to osteoarthritis (OA), which impairs patient quality of life and creates substantial socioeconomic burdens worldwide. Mesenchymal stem cells (MSCs) offer a promising approach for cartilage regeneration; however, comparative data on the efficacy of MSCs from different tissue sources for ankle cartilage repair remains limited. As an exploratory preclinical study, this investigation aimed to evaluate and compare the effects of bone marrow-derived MSCs (BMMSCs), adipose-derived MSCs (ADMSCs), and synovial fluid-derived MSCs (SFMSCs) in a rat model of full-thickness talar cartilage defects. Full-thickness talar cartilage defects were created by limited-depth drilling in 8-week-old male Sprague-Dawley rats (200–300 g). Animals were randomly assigned to a control group or three treatment groups receiving intra-articular injection of BMMSCs, ADMSCs, or SFMSCs. Outcomes were assessed using behavioral and gait tests, footprint analysis, Micro-CT imaging for subchondral bone parameters (BS/TV, Tb.N, Tb.Sp), ICRS macroscopic scoring, histopathological evaluation, and immunohistochemical staining for chondrogenic markers (Col II, FSTL1, SOX9, Smad3). In this exploratory analysis, the SFMSC group displayed comparatively better functional recovery in behavioral and gait measurements relative to other groups. The footprint length factor was significantly higher in the SFMSC group (6.76 ± 1.15) than in the control group (5.52 ± 1.68, P < 0.05), and the ICRS score was also elevated in the SFMSC group (11.00 ± 1.26 vs. 8.80 ± 1.32 in controls, P < 0.01). No significant differences in subchondral bone Micro-CT parameters were detected among groups (P > 0.05). Histological and immunohistochemical findings suggested that SFMSCs were associated with enhanced hyaline cartilage formation and relatively higher expression of chondrogenic markers at the defect site. Within the constraints of this exploratory preclinical study, SFMSCs showed comparatively favorable effects on talar cartilage repair in rats relative to BMMSCs and ADMSCs. These preliminary findings support SFMSCs as a promising candidate source for stem cell-based ankle cartilage regeneration, providing exploratory evidence that may inform future investigations toward clinical translation.
- Open Access
- 20 April 2026
- Published by Taylor & Francis in Future Science OA
- Vol. 12 (1) , 2658207
The regulatory significance of chondrocyte hypertrophy in maintaining chondrocyte homeostasis, regeneration and repair
Chondrocyte hypertrophy is a pivotal biological process in skeletal development and disease progression, with its precise regulation being essential for maintaining cartilage homeostasis and promoting tissue repair. This review systematically summarizes the molecular mechanisms of chondrocyte hypertrophy and its roles in both physiology and pathology, with a focus on its central involvement in osteoarthritis (OA), growth plate dysplasia, and heterotopic ossification. Key signaling pathways, including RUNX2, BMP, Wnt/β-catenin, and PTHrP, orchestrate hypertrophy through intricate crosstalk. Conversely, inhibitory factors such as SOX9, HIFs, and miRNAs preserve chondrocyte phenotype stability. Pathologically, dysregulated hypertrophy drives cartilage matrix degradation, metabolic reprogramming, and pro-inflammatory microenvironments, thereby exacerbating OA progression. Single-cell omics has unveiled cellular heterogeneity in OA cartilage, and innovative biomaterials combined with stem cell therapies offer promising regenerative approaches. However, limitations persist in understanding pathway interactions, replicating in vivo complexity in vitro, and translating findings to clinical applications. Future research should integrate multidisciplinary technologies to develop precise therapeutic strategies, advancing the treatment of cartilage-related disorders. This review is designed as a narrative review, aiming to systematically synthesize the molecular mechanisms, pathophysiological roles, and therapeutic implications of chondrocyte hypertrophy.
- 20 April 2026
- Published by Taylor & Francis in Future Science OA
- Vol. 12 (1) , 2658207
Open AccessThe regulatory significance of chondrocyte hypertrophy in maintaining chondrocyte homeostasis, regeneration and repair
Chondrocyte hypertrophy is a pivotal biological process in skeletal development and disease progression, with its precise regulation being essential for maintaining cartilage homeostasis and promoting tissue repair. This review systematically summarizes the molecular mechanisms of chondrocyte hypertrophy and its roles in both physiology and pathology, with a focus on its central involvement in osteoarthritis (OA), growth plate dysplasia, and heterotopic ossification. Key signaling pathways, including RUNX2, BMP, Wnt/β-catenin, and PTHrP, orchestrate hypertrophy through intricate crosstalk. Conversely, inhibitory factors such as SOX9, HIFs, and miRNAs preserve chondrocyte phenotype stability. Pathologically, dysregulated hypertrophy drives cartilage matrix degradation, metabolic reprogramming, and pro-inflammatory microenvironments, thereby exacerbating OA progression. Single-cell omics has unveiled cellular heterogeneity in OA cartilage, and innovative biomaterials combined with stem cell therapies offer promising regenerative approaches. However, limitations persist in understanding pathway interactions, replicating in vivo complexity in vitro, and translating findings to clinical applications. Future research should integrate multidisciplinary technologies to develop precise therapeutic strategies, advancing the treatment of cartilage-related disorders. This review is designed as a narrative review, aiming to systematically synthesize the molecular mechanisms, pathophysiological roles, and therapeutic implications of chondrocyte hypertrophy.
- Open Access
- 3 April 2026
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 9 (5) , 932-946
Genetic prediction of blood cell reactivity and its potential causal influence on bone continuity and density disorders
Background: This study aimed to investigate the potential causal relationship between genetically predicted human blood cell (HBC) reactivity and disorders of bone continuity, density, and structure. Methods: We analyzed summary‐level GWAS data for 91 HBC traits and two bone‐related outcomes from publicly available sources, employing the inverse‐variance weighted (IVW) method as the principal Mendelian randomization (MR) technique. The sensitivity analyses comprised MR‐Egger regression and MR‐PRESSO. Results: MR analysis identified suggestive associations between red blood cell (RBC) perturbation response (Pam3CSK4), neutrophil perturbation response (side fluorescence coefficient of variation of neutrophil 4), Neutrophil perturbation response (colchicine), Monocyte perturbation response (TMAO perturbation) and bone continuity. The MR results are: [ β : −0.13, odds ratio (OR): 0.88; 95% confidence interval (CI): 0.77, 0.99; p = 0.040], [ β : 0.11, OR: 1.12, 95% CI: 1.02, 1.23; p = 0.016], [ β : −0.11, OR: 0.90, 95% CI: 0.81, 0.99; p = 0.029] and [ β : −0.04, OR: 0.96, 95% CI: 0.92, 0.99; p = 0.023]. In addition, Neutrophil perturbation response (forward scatter median of neutrophil 1), Unknown cell population perturbation response (nigericin) and other disorders of bone density and structure are also potential causal factors, with MR Result [ β : 0.21, OR: 1.24, 95%CI: 1.01, 1.51; p = 0.034], [ β : 0.03, OR: 1.03, 95% CI: 1.00, 1.06; p = 0.042]. Reverse Mendelian randomization sensitivity analysis showed a potential bidirectional association between specific HBC features and bone‐related outcomes. Conclusions: This exploratory study offer valuable preliminary insights into the blood cell functional reactivity and bone health. The findings, while requiring independent validation, highlight plausible biological pathways for further elucidation.
- 3 April 2026
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 9 (5) , 932-946
Open AccessGenetic prediction of blood cell reactivity and its potential causal influence on bone continuity and density disorders
Background: This study aimed to investigate the potential causal relationship between genetically predicted human blood cell (HBC) reactivity and disorders of bone continuity, density, and structure. Methods: We analyzed summary‐level GWAS data for 91 HBC traits and two bone‐related outcomes from publicly available sources, employing the inverse‐variance weighted (IVW) method as the principal Mendelian randomization (MR) technique. The sensitivity analyses comprised MR‐Egger regression and MR‐PRESSO. Results: MR analysis identified suggestive associations between red blood cell (RBC) perturbation response (Pam3CSK4), neutrophil perturbation response (side fluorescence coefficient of variation of neutrophil 4), Neutrophil perturbation response (colchicine), Monocyte perturbation response (TMAO perturbation) and bone continuity. The MR results are: [ β : −0.13, odds ratio (OR): 0.88; 95% confidence interval (CI): 0.77, 0.99; p = 0.040], [ β : 0.11, OR: 1.12, 95% CI: 1.02, 1.23; p = 0.016], [ β : −0.11, OR: 0.90, 95% CI: 0.81, 0.99; p = 0.029] and [ β : −0.04, OR: 0.96, 95% CI: 0.92, 0.99; p = 0.023]. In addition, Neutrophil perturbation response (forward scatter median of neutrophil 1), Unknown cell population perturbation response (nigericin) and other disorders of bone density and structure are also potential causal factors, with MR Result [ β : 0.21, OR: 1.24, 95%CI: 1.01, 1.51; p = 0.034], [ β : 0.03, OR: 1.03, 95% CI: 1.00, 1.06; p = 0.042]. Reverse Mendelian randomization sensitivity analysis showed a potential bidirectional association between specific HBC features and bone‐related outcomes. Conclusions: This exploratory study offer valuable preliminary insights into the blood cell functional reactivity and bone health. The findings, while requiring independent validation, highlight plausible biological pathways for further elucidation.
- Open Access
- 4 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 162
Sinus Tarsi Morphometry Is Correlated with Flatfoot Severity on Weight-Bearing CT
Background: Flexible flatfoot is a common musculoskeletal disorder in adolescents, which is characterized by a collapsed longitudinal arch. A common surgery like subtalar arthroereisis depends on the implant in sinus tarsi. Optimal match between them can potentially avoid postoperative pain and obtain improved prognosis. Investigations into anatomical morphology of sinus tarsi by weight-bearing CT (WBCT) may unveil the pathogenesis and facilitate the treatment of flexible flatfoot. Methods: This retrospective study included 28 control cases and 42 flatfoot cases. The sinus tarsi length (STL), the sinus tarsi width (STW), the angle between its long axis and the horizontal line (ST-H angle), the sinus tarsi angle (ST angle), and the tibial width were measured. We also calculated two ratios (STL/tibia width and STW/tibia width) to standardize individual differences. Data analysis was conducted via mean/median comparisons and subsequent linear regression. Results: The STL and the STL/tibia width were significantly greater in the flatfoot group (25.73 ± 3.50 vs. 23.09 ± 3.77 mm, p = 0.004; 0.90 ± 0.15 vs. 0.81 ± 0.14, p = 0.009). The ST angle was significantly smaller in the flatfoot group by an average of 4.63° (13.20° vs. 17.83°, p < 0.001). Linear regression revealed that female gender and smaller ST angle were significantly correlated with higher Meary angle, while smaller ST angle and greater STL/tibia width were significantly correlated with lower Pitch angle (p = 0.002, p = 0.007; p = 0.003, p = 0.004). No statistical predictive effects were observed for the other variables. Conclusions: The ST angle and STL/tibia width may serve as auxiliary parameters for implant selection in subtalar arthroereisis to improve sizing match within the sinus tarsi.
- 4 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 162
Open AccessSinus Tarsi Morphometry Is Correlated with Flatfoot Severity on Weight-Bearing CT
Background: Flexible flatfoot is a common musculoskeletal disorder in adolescents, which is characterized by a collapsed longitudinal arch. A common surgery like subtalar arthroereisis depends on the implant in sinus tarsi. Optimal match between them can potentially avoid postoperative pain and obtain improved prognosis. Investigations into anatomical morphology of sinus tarsi by weight-bearing CT (WBCT) may unveil the pathogenesis and facilitate the treatment of flexible flatfoot. Methods: This retrospective study included 28 control cases and 42 flatfoot cases. The sinus tarsi length (STL), the sinus tarsi width (STW), the angle between its long axis and the horizontal line (ST-H angle), the sinus tarsi angle (ST angle), and the tibial width were measured. We also calculated two ratios (STL/tibia width and STW/tibia width) to standardize individual differences. Data analysis was conducted via mean/median comparisons and subsequent linear regression. Results: The STL and the STL/tibia width were significantly greater in the flatfoot group (25.73 ± 3.50 vs. 23.09 ± 3.77 mm, p = 0.004; 0.90 ± 0.15 vs. 0.81 ± 0.14, p = 0.009). The ST angle was significantly smaller in the flatfoot group by an average of 4.63° (13.20° vs. 17.83°, p < 0.001). Linear regression revealed that female gender and smaller ST angle were significantly correlated with higher Meary angle, while smaller ST angle and greater STL/tibia width were significantly correlated with lower Pitch angle (p = 0.002, p = 0.007; p = 0.003, p = 0.004). No statistical predictive effects were observed for the other variables. Conclusions: The ST angle and STL/tibia width may serve as auxiliary parameters for implant selection in subtalar arthroereisis to improve sizing match within the sinus tarsi.
- Open Access
- 1 November 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (11) , 634-641
Loadless Tendon Explant Model Exhibits Spontaneous Degradative Phenotypes: An In Vitro Study of Human Tendons
Background: Although the tendon explant model has been gradually recognized for simulating tendon characteristics in vitro, there is still no consensus on a standardized culture protocol. Recently, tendon explants have been applied to senescence-related research but whether their own changes affected the credibility of the conclusions was not confirmed. Therefore, this study aimed to systematically evaluate the reliability of the loadless tendon explant model by characterizing its dynamic macroscopic morphological and molecular biological changes during culture. Methods: This study collected surgical samples from patients as loadless tendon explants for culture and conducted molecular biology and cytology tests once every 3 days within 15 days. Both their macroscopic and microscopic changes were recorded and analyzed, with each compared to the corresponding parameters at day 0. Results: Loadless tendon explants spontaneously underwent progressive disintegration, leading to the collapse of the original dense structure. Consistently, the collagen fibers also gradually became loose and fractured, contributing to a significant decrease of collage density from day 9. In addition, the senescence and apoptosis markers P21 and Caspase 3 increased over time, and there were statistically significant differences starting from day 6, respectively. The main intrinsic component, Collagen I, and the main catabolic enzyme, metalloproteinase 13 (MMP 13), could hardly be detected since day 3. During the daily evaluations from day 0 to day 4, Collagen I gradually decreased and was barely detectable by day 3, whereas MMP 13 increased on day 1 followed by a rapid decline since day 2. Conclusions: These results indicate that loadless tendon explants rapidly degrade and lose matrix integrity, with their spontaneous changes compromising the reliability of research conclusions related to senescence and apoptosis. Therefore, further optimization is still required before a well-established protocol is applied.
- 1 November 2025
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 17 (11) , 634-641
Open AccessLoadless Tendon Explant Model Exhibits Spontaneous Degradative Phenotypes: An In Vitro Study of Human Tendons
Background: Although the tendon explant model has been gradually recognized for simulating tendon characteristics in vitro, there is still no consensus on a standardized culture protocol. Recently, tendon explants have been applied to senescence-related research but whether their own changes affected the credibility of the conclusions was not confirmed. Therefore, this study aimed to systematically evaluate the reliability of the loadless tendon explant model by characterizing its dynamic macroscopic morphological and molecular biological changes during culture. Methods: This study collected surgical samples from patients as loadless tendon explants for culture and conducted molecular biology and cytology tests once every 3 days within 15 days. Both their macroscopic and microscopic changes were recorded and analyzed, with each compared to the corresponding parameters at day 0. Results: Loadless tendon explants spontaneously underwent progressive disintegration, leading to the collapse of the original dense structure. Consistently, the collagen fibers also gradually became loose and fractured, contributing to a significant decrease of collage density from day 9. In addition, the senescence and apoptosis markers P21 and Caspase 3 increased over time, and there were statistically significant differences starting from day 6, respectively. The main intrinsic component, Collagen I, and the main catabolic enzyme, metalloproteinase 13 (MMP 13), could hardly be detected since day 3. During the daily evaluations from day 0 to day 4, Collagen I gradually decreased and was barely detectable by day 3, whereas MMP 13 increased on day 1 followed by a rapid decline since day 2. Conclusions: These results indicate that loadless tendon explants rapidly degrade and lose matrix integrity, with their spontaneous changes compromising the reliability of research conclusions related to senescence and apoptosis. Therefore, further optimization is still required before a well-established protocol is applied.
- Open Access
- 1 October 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (4)
Exploring the Therapeutic Potential of Virtual Screened Novel HER2 Inhibitors via QSAR, Molecular Docking and Dynamics Simulations
Objectives: HER2 overexpression is almost invariably associated with advanced breast cancer disease and poor prognosis, hence its extensive review. This study therefore aims to discover and analyze potential HER2 inhibitors through computational methods to advance drug discovery and optimization. Methodology: A ligand-based virtual screening (LBVS) approach was employed to screen compounds from the ChEMBL database. From 8900 initial matches, 39 candidate compounds were selected based on structural similarity and ADME properties. Molecular docking was performed to assess binding affinity with HER2, followed by molecular dynamics (MD) simulations to evaluate complex stability. Additionally, a QSAR (quantitative structure-activity relationship) model was established to elucidate key structural features influencing inhibitory activity. Results: Five lead compounds were prioritized based on strong docking scores (<−8.4 kcal/mol). Among them, compound 2048788 (−11.0 kcal/mol, predicted pIC 50 ≈ 8.6) and compound 3956509 (pIC 50 ≈ 8.4) showed superior binding affinity and pharmacokinetic properties compared to FDA-approved drugs (doxorubicin, letrozole, lanatuzumab). MD simulations confirmed complex stability. The initial QSAR model showed low predictive power (R 2 = 0.18, RMSE = 1.19), but after feature selection, performance improved significantly (RMSE = 0.57). Key positive contributors included hydrogen bond donor count (r = 0.63), lipophilicity (LogP, r = 0.60), and sp 3 carbon fraction (r =0.60), while excessive polarity and aromaticity reduced activity. Compounds within the 450-500 Da molecular weight range exhibited the highest activity (pIC 50 = 8.0-8.6). Conclusion: This study integrated virtual screening, docking, MD simulations, and QSAR modeling to identify compound 2048788 as a highly promising HER2 inhibitor. These findings provide a strong foundation for further optimization and the preclinical development of targeted HER2 therapies.
- 1 October 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (4)
Open AccessExploring the Therapeutic Potential of Virtual Screened Novel HER2 Inhibitors via QSAR, Molecular Docking and Dynamics Simulations
Objectives: HER2 overexpression is almost invariably associated with advanced breast cancer disease and poor prognosis, hence its extensive review. This study therefore aims to discover and analyze potential HER2 inhibitors through computational methods to advance drug discovery and optimization. Methodology: A ligand-based virtual screening (LBVS) approach was employed to screen compounds from the ChEMBL database. From 8900 initial matches, 39 candidate compounds were selected based on structural similarity and ADME properties. Molecular docking was performed to assess binding affinity with HER2, followed by molecular dynamics (MD) simulations to evaluate complex stability. Additionally, a QSAR (quantitative structure-activity relationship) model was established to elucidate key structural features influencing inhibitory activity. Results: Five lead compounds were prioritized based on strong docking scores (<−8.4 kcal/mol). Among them, compound 2048788 (−11.0 kcal/mol, predicted pIC 50 ≈ 8.6) and compound 3956509 (pIC 50 ≈ 8.4) showed superior binding affinity and pharmacokinetic properties compared to FDA-approved drugs (doxorubicin, letrozole, lanatuzumab). MD simulations confirmed complex stability. The initial QSAR model showed low predictive power (R 2 = 0.18, RMSE = 1.19), but after feature selection, performance improved significantly (RMSE = 0.57). Key positive contributors included hydrogen bond donor count (r = 0.63), lipophilicity (LogP, r = 0.60), and sp 3 carbon fraction (r =0.60), while excessive polarity and aromaticity reduced activity. Compounds within the 450-500 Da molecular weight range exhibited the highest activity (pIC 50 = 8.0-8.6). Conclusion: This study integrated virtual screening, docking, MD simulations, and QSAR modeling to identify compound 2048788 as a highly promising HER2 inhibitor. These findings provide a strong foundation for further optimization and the preclinical development of targeted HER2 therapies.
- Open Access
- 27 March 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 379-389
Comparative study of chitosan-based liquid dressing and recombinant human epidermal growth factor on acute limb skin wound healing: A randomized controlled trial
- 27 March 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 379-389
Open AccessComparative study of chitosan-based liquid dressing and recombinant human epidermal growth factor on acute limb skin wound healing: A randomized controlled trial
- Top Cited PapersOpen Access
- 3 December 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-22
Cellular crosstalk in the bone marrow niche
The bone marrow niche is a special microenvironment that comprises elements, including hematopoietic stem cells, osteoblasts, and endothelial cells, and helps maintain their characteristic functions. Here, we elaborate on the crosstalk between various cellular components, hematopoietic stem cells, and other cells in the bone marrow niche. We further explain the mechanism of preserving equilibrium in the bone marrow niche, which is crucial for the directional regulation of bone reconstruction and repair. Additionally, we elucidate the intercommunication among osteocytes, the regulation of osteoblast maturation and activation by lymphocytes, the deficiency of megakaryocytes that can markedly impair osteoblast formation, and the mechanism of interaction between macrophages and mesenchymal stem cells in the bone marrow niche. Finally, we discussed the new immunotherapies for bone tumors in the BM niche. In this review, we aimed to provide a candid overview of the crosstalk among bone marrow niche cells and to highlight new concepts underlying the unknown mechanisms of hematopoiesis and bone reconstruction. Thus, this review may provide a more comprehensive understanding of the role of these niche cells in improving hematopoietic function and help identify their therapeutic potential for different diseases in the future.
- 3 December 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-22
Top Cited PapersOpen AccessCellular crosstalk in the bone marrow niche
The bone marrow niche is a special microenvironment that comprises elements, including hematopoietic stem cells, osteoblasts, and endothelial cells, and helps maintain their characteristic functions. Here, we elaborate on the crosstalk between various cellular components, hematopoietic stem cells, and other cells in the bone marrow niche. We further explain the mechanism of preserving equilibrium in the bone marrow niche, which is crucial for the directional regulation of bone reconstruction and repair. Additionally, we elucidate the intercommunication among osteocytes, the regulation of osteoblast maturation and activation by lymphocytes, the deficiency of megakaryocytes that can markedly impair osteoblast formation, and the mechanism of interaction between macrophages and mesenchymal stem cells in the bone marrow niche. Finally, we discussed the new immunotherapies for bone tumors in the BM niche. In this review, we aimed to provide a candid overview of the crosstalk among bone marrow niche cells and to highlight new concepts underlying the unknown mechanisms of hematopoiesis and bone reconstruction. Thus, this review may provide a more comprehensive understanding of the role of these niche cells in improving hematopoietic function and help identify their therapeutic potential for different diseases in the future.
- Open Access
- 29 July 2024
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 54 (4) , 1-17
TMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review)
TMEM16 proteins, which function as Ca2+‑activated Cl‑ channels are involved in regulating a wide variety of cellular pathways and functions. The modulators of Cl‑ channels can be used for the molecule‑based treatment of respiratory diseases, cystic fibrosis, tumors, cancer, osteoporosis and coronavirus disease 2019. The TMEM16 proteins link Ca2+ signaling, cellular electrical activity and lipid transport. Thus, deciphering these complex regulatory mechanisms may enable a more comprehensive understanding of the physiological functions of the TMEM16 proteins and assist in ascertaining the applicability of these proteins as potential pharmacological targets for the treatment of a range of diseases. The present review examined the structures, functions and characteristics of the different types of TMEM16 proteins, their association with the pathogenesis of various diseases and the applicability of TMEM16 modulator‑based treatment methods.
- 29 July 2024
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 54 (4) , 1-17
Open AccessTMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review)
TMEM16 proteins, which function as Ca2+‑activated Cl‑ channels are involved in regulating a wide variety of cellular pathways and functions. The modulators of Cl‑ channels can be used for the molecule‑based treatment of respiratory diseases, cystic fibrosis, tumors, cancer, osteoporosis and coronavirus disease 2019. The TMEM16 proteins link Ca2+ signaling, cellular electrical activity and lipid transport. Thus, deciphering these complex regulatory mechanisms may enable a more comprehensive understanding of the physiological functions of the TMEM16 proteins and assist in ascertaining the applicability of these proteins as potential pharmacological targets for the treatment of a range of diseases. The present review examined the structures, functions and characteristics of the different types of TMEM16 proteins, their association with the pathogenesis of various diseases and the applicability of TMEM16 modulator‑based treatment methods.
- Open Access
- 7 November 2023
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 53 (1) , 1-17
Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review)
Osteoarthritis (OA) is a chronic joint disease characterized by articular cartilage degeneration, secondary bone hyperplasia, inadequate extracellular matrix synthesis and degeneration of articular cartilage. Mesenchymal stem cells (MSCs) can self‑renew and undergo multidirectional differentiation; they can differentiate into chondrocytes. Aging MSCs have a weakened ability to differentiate, and release various pro‑inflammatory cytokines, which may contribute to OA progression; the other mechanism contributing to OA is epigenetic regulation (for instance, DNA methylation, histone modification and regulation of non‑coding RNA). Owing to the self‑renewal and differentiation ability of MSCs, various MSC‑based exogenous cell therapies have been developed to treat OA. The efficacy of MSC‑based therapy is mainly attributed to cytokines, growth factors and the paracrine effect of exosomes. Recently, extensive studies have been conducted on MSC‑derived exosomes. Exosomes from MSCs can deliver a variety of DNA, RNA, proteins and lipids, thereby facilitating MSC migration and cartilage repair. Therefore, MSC‑derived exosomes are considered a promising therapy for OA. The present review summarized the association between MSC aging and OA in terms of genetics and epigenetics, and characteristics of MSC‑derived exosomes, and the mechanism to alleviate OA cartilage damage.
- 7 November 2023
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 53 (1) , 1-17
Open AccessSingle‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review)
Osteoarthritis (OA) is a chronic joint disease characterized by articular cartilage degeneration, secondary bone hyperplasia, inadequate extracellular matrix synthesis and degeneration of articular cartilage. Mesenchymal stem cells (MSCs) can self‑renew and undergo multidirectional differentiation; they can differentiate into chondrocytes. Aging MSCs have a weakened ability to differentiate, and release various pro‑inflammatory cytokines, which may contribute to OA progression; the other mechanism contributing to OA is epigenetic regulation (for instance, DNA methylation, histone modification and regulation of non‑coding RNA). Owing to the self‑renewal and differentiation ability of MSCs, various MSC‑based exogenous cell therapies have been developed to treat OA. The efficacy of MSC‑based therapy is mainly attributed to cytokines, growth factors and the paracrine effect of exosomes. Recently, extensive studies have been conducted on MSC‑derived exosomes. Exosomes from MSCs can deliver a variety of DNA, RNA, proteins and lipids, thereby facilitating MSC migration and cartilage repair. Therefore, MSC‑derived exosomes are considered a promising therapy for OA. The present review summarized the association between MSC aging and OA in terms of genetics and epigenetics, and characteristics of MSC‑derived exosomes, and the mechanism to alleviate OA cartilage damage.